Upgrade to SI Premium - Free Trial

Fennec Pharmaceuticals (FENC)

8.90 +0.20 (2.30%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (8/6/26)

Latest Headlines

Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Raykov Rosty June 2, 2026 4:06 PM - SEC Filing Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty June 1, 2026 4:14 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Cioffi Christiana Marie June 1, 2026 4:08 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Hackman Jeffrey S. June 1, 2026 4:07 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Evans Terry L June 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Sayad Pierre Sargis June 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: May 31 Filed by: Andrade Robert June 1, 2026 4:06 PM - SEC Filing Form 8-K FENNEC PHARMACEUTICALS For: May 21 May 22, 2026 4:06 PM - SEC Filing Fennec Pharmaceuticals Inc. (FENC) PT Raised to $16 at H.C. Wainwright May 22, 2026 6:50 AM - StreetInsider Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting May 21, 2026 6:01 PM - Globe NewsWire Form 8-K FENNEC PHARMACEUTICALS For: May 18 May 18, 2026 5:12 PM - SEC Filing Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) May 18, 2026 4:30 PM - Globe NewsWire Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: Solas Capital Management, LLC May 15, 2026 10:59 AM - SEC Filing Form 10-Q FENNEC PHARMACEUTICALS For: Mar 31 May 14, 2026 4:25 PM - SEC Filing Form SCHEDULE 13G/A FENNEC PHARMACEUTICALS Filed by: Rosalind Advisors, Inc. May 14, 2026 2:50 PM - SEC Filing Fennec Pharmaceuticals (FENC) Tops Q1 EPS by 5c May 14, 2026 6:31 AM - StreetInsider Fennec Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update May 14, 2026 6:30 AM - Globe NewsWire Form 4 FENNEC PHARMACEUTICALS For: May 11 Filed by: RALLIS CHRIS A May 12, 2026 4:06 PM - SEC Filing Form 144 FENNEC PHARMACEUTICALS Filed by: RALLIS CHRIS A May 11, 2026 4:17 PM - SEC Filing Fennec Pharmaceuticals to Report First Quarter 2026 Financial Results on May 14, 2026 May 7, 2026 6:36 AM - Globe NewsWire Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Raykov Rosty May 1, 2026 5:01 PM - SEC Filing Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty May 1, 2026 4:16 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Cioffi Christiana Marie May 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Evans Terry L May 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Hackman Jeffrey S. May 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Sayad Pierre Sargis May 1, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Apr 30 Filed by: Andrade Robert May 1, 2026 4:06 PM - SEC Filing Form 8-K FENNEC PHARMACEUTICALS For: Apr 27 April 28, 2026 4:46 PM - SEC Filing Form SCHEDULE 13G FENNEC PHARMACEUTICALS Filed by: HIRSCHMAN ORIN April 28, 2026 4:16 PM - SEC Filing Form DEF 14A FENNEC PHARMACEUTICALS For: Jun 10 April 28, 2026 4:10 PM - SEC Filing Form 8-K FENNEC PHARMACEUTICALS For: Apr 22 April 22, 2026 4:05 PM - SEC Filing H.C. Wainwright Reiterates Buy Rating on Fennec Pharmaceuticals Inc. (FENC) April 8, 2026 7:15 AM - StreetInsider Form 8-K FENNEC PHARMACEUTICALS For: Apr 07 April 7, 2026 4:27 PM - SEC Filing Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center April 7, 2026 10:41 AM - Globe NewsWire Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Cioffi Christiana Marie April 2, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Hackman Jeffrey S. April 2, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 31 Filed by: Raykov Rosty April 2, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Sayad Pierre Sargis April 2, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Evans Terry L April 2, 2026 4:06 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 28 Filed by: Andrade Robert April 2, 2026 4:06 PM - SEC Filing Form 144 FENNEC PHARMACEUTICALS Filed by: Raykov Rosty April 1, 2026 4:38 PM - SEC Filing Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) March 31, 2026 6:00 AM - Globe NewsWire Form 10-K FENNEC PHARMACEUTICALS For: Dec 31 March 27, 2026 4:44 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 26 Filed by: Andrade Robert March 26, 2026 4:31 PM - SEC Filing Form 4 FENNEC PHARMACEUTICALS For: Mar 26 Filed by: Cioffi Christiana Marie March 26, 2026 4:29 PM - SEC Filing Form 8-K FENNEC PHARMACEUTICALS For: Mar 24 March 24, 2026 4:23 PM - SEC Filing Fennec Pharmaceuticals (FENC) Misses Q4 EPS by 20c March 24, 2026 7:02 AM - StreetInsider Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update March 24, 2026 7:01 AM - Globe NewsWire Form 8-K FENNEC PHARMACEUTICALS For: Mar 16 March 16, 2026 5:21 PM - SEC Filing Fennec settles patent dispute with Cipla over PEDMARK generic March 16, 2026 8:09 AM - StreetInsider Fennec Pharmaceuticals Announces Settlement Agreement Resolving PEDMARK Patent Litigation March 16, 2026 8:08 AM - Globe NewsWire Form 4 FENNEC PHARMACEUTICALS For: Feb 18 Filed by: Andrade Robert March 11, 2026 7:02 PM - SEC Filing Full Article List